Javascript must be enabled to continue!
Kinetic Spectrophotometric Method for the Determination of Ranitidine and Nizatidine in Pharmaceuticals
View through CrossRef
Abstract
An accurate and simple kinetic method is described for the determination of ranitidine and nizatidine in pure form and in pharmaceuticals. The method is based on the reaction of the compounds with 7-chloro-4-nitrobenz-2-oxa-1,3-diazole in pH 7.4 borate buffer at 60°C for a fixed time of 25 min for both compounds. The absorbance of the reaction product is measured at 495 nm for ranitidine and nizatidine. Calibration graphs were linear over the concentration range of 2–20 μg/mL, with limits of detection of 0.13 (3.7 × 10−7M) and 0.25 μg/mL (7.5 × 10−7M) for ranitidine and nizatidine, respectively. The proposed method was applied successfully to the determination of ranitidine in tablets and ampoules with average recoveries of 100.26 ± 0.69 and 100.29 ± 0.59%, respectively, and to the determination of nizatidine in capsules with an average recovery of 104.26 ± 0.44%. The results obtained are in good agreement with those obtained by the other methods used for comparison. A proposal of the reaction pathway is also presented.
Oxford University Press (OUP)
Title: Kinetic Spectrophotometric Method for the Determination of Ranitidine and Nizatidine in Pharmaceuticals
Description:
Abstract
An accurate and simple kinetic method is described for the determination of ranitidine and nizatidine in pure form and in pharmaceuticals.
The method is based on the reaction of the compounds with 7-chloro-4-nitrobenz-2-oxa-1,3-diazole in pH 7.
4 borate buffer at 60°C for a fixed time of 25 min for both compounds.
The absorbance of the reaction product is measured at 495 nm for ranitidine and nizatidine.
Calibration graphs were linear over the concentration range of 2–20 μg/mL, with limits of detection of 0.
13 (3.
7 × 10−7M) and 0.
25 μg/mL (7.
5 × 10−7M) for ranitidine and nizatidine, respectively.
The proposed method was applied successfully to the determination of ranitidine in tablets and ampoules with average recoveries of 100.
26 ± 0.
69 and 100.
29 ± 0.
59%, respectively, and to the determination of nizatidine in capsules with an average recovery of 104.
26 ± 0.
44%.
The results obtained are in good agreement with those obtained by the other methods used for comparison.
A proposal of the reaction pathway is also presented.
Related Results
Comprehensive analysis of nizatidine: Pharmacodynamics and pharmacokinetics in anti-ulcer treatment
Comprehensive analysis of nizatidine: Pharmacodynamics and pharmacokinetics in anti-ulcer treatment
Ulcers are characterized histologically as lesions that penetrate through the muscularis mucosae into the submucosal layer, affecting any segment of the gastrointestinal (GI) tract...
Development and validation of high‐performance liquid chromatography‐Orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction
Development and validation of high‐performance liquid chromatography‐Orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction
Rationale
N
‐Nitroso dimethylamine (NDMA) is a mutagenic impurity detected in several ranitidine products. The amin...
Effectiveness Of Ranitidine Providing Compared With Omeprazol In Children With Gastroesofageal Reflux Disease
Effectiveness Of Ranitidine Providing Compared With Omeprazol In Children With Gastroesofageal Reflux Disease
Background. The drugs that are often given to children with GERD are stomach acidsuppressants, namely the H2 receptor antagonist and proton pump inhibitor (PPI) classof drugs, but ...
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan
Polypharmacy may be considered as the customary practice to provide optimum care services to patients but inter resulted in augmented probability of multiple drug interaction. Keep...
New reagents for the spectrophotometric determination of ranitidine hydrochloride
New reagents for the spectrophotometric determination of ranitidine hydrochloride
A new spectrophotometric method is proposed for the assay of ranitidine hydrochloride (RNH) in bulk drug and in its dosage forms using ceric ammonium sulphate (CAS) and two dyes, m...
Comparison of 1‐week vs. 2‐ or 4‐week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
Comparison of 1‐week vs. 2‐ or 4‐week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
Background: Helicobacter pylori eradication therapies based on ranitidine bismuth citrate have recently been introduced in clinical practice.Aim:To compare the efficacy of three re...
SYNERGISTIC DRUG-DRUG INTERACTION;
SYNERGISTIC DRUG-DRUG INTERACTION;
Introduction: Ranitidine is known to us all as an anti-ulcer drug which acts byblocking H2 receptors in the stomach parietal cells. However its role in this category has beenunders...
From Acid Reflux to Health Hazard: The Growing Cancer Threat Associated with Ranitidine
From Acid Reflux to Health Hazard: The Growing Cancer Threat Associated with Ranitidine
Ranitidine is a medication used for heart burn,
stomach ulcer, gastroesophageal reflux disorder
and other conditions that cause an accumulation of
stomach acid. The side/adverse ef...

